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Abstract
Background: The prevalence of chronic kidney disease (CKD) in St. Kitts and Nevis, islands of the West Indies, is
unknown. We sought to determine estimates of CKD and its risk factors (e.g. diabetes, hypertension and obesity) in
St. Kitts and Nevis.
Methods: This was a chronic disease screening program. Three community-based locations in St. Kitts and Nevis
were included in the program. Participants were adult community residents aged ≥18 years. The main outcome
measures were estimated CKD prevalence (by serum creatinine-based estimated glomerular filtration rate (eGFR)
and dipstick urine albumin); and estimated prevalence of CKD risk factors (diabetes, hypertension and obesity).
Logistic regression was used to determine independent predictors of CKD.
Results: One thousand nine hundred seventy eight persons, from Nevis (n = 950) and St. Kitts (n = 1028) were
screened by the Caribbean Health and Education Foundation. Participants’ mean age was 49 ± 15 years, 65% were
female, and 99% were black. Fully, 21.5% had diabetes and 53.1% had hypertension; and 40.3% were obese. Mean
estimated eGFR was 98 ml/min/1.73 m2 (standard deviation = 30) and 4.7% had an eGFR <60 ml/min/1.73 m2,
indicating CKD. Age [Odds Ratio (OR) = 1.08, 95% Confidence Interval (CI) 1.05–1.11], hypertension (OR = 2.89, 95%
CI 1.18–7.07) and diabetes (OR = 3.12, 95% CI 1.80–5.43) were independent predictors of reduced eGFR in models
adjusted for age, gender and obesity status. Of those with urine testing in Nevis (n = 929), 13.5% had urine
albumin ≥30 mg/dL, and diabetes was an independent predictor of this finding (OR = 2.43, 95% CI 1.53–3.87).
Conclusions: CKD and its risk factors were prevalent among adults in St. Kitts and Nevis. Public policy strategies for
prevention and treatment of these conditions may be needed to reduce their associated morbidity, mortality and costs.
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Background
Non-communicable chronic diseases such as stroke,
heart disease, diabetes, and hypertension are the leading
causes of death in the member countries of the
Organization of Eastern Caribbean States (which includes
Antigua and Barbuda, Commonwealth of Dominica,
Grenada, Montserrat, St. Kitts and Nevis, St. Lucia and St.
Vincent and the Grenadines), like that of the wider region,
accounting for over half of deaths [1]. Diabetes and hyper-
tension are the two major causes of chronic kidney disease
(CKD) and end stage renal disease (ESRD) worldwide [2].
Reports from the Caribbean Renal Registry (CRR) also
indicate diabetes and hypertension are the leading causes
of CKD and ESRD in the Caribbean [2, 3]. Little is known
regarding the prevalence of CKD in the Caribbean,
particularly in St. Kitts and Nevis.
The Federation of St. Kitts and Nevis, also known as
the Federation of Saint Christopher and Nevis, is a
two-island country in the West Indies. The capital city
is Basseterre on the larger island of St. Kitts and the
smaller island of Nevis lies about 2 miles (3 km)
southeast of St. Kitts. Persons residing on St. Kitts
* Correspondence: dcrews1@jhmi.edu
1Division of Nephrology, Department of Medicine, Johns Hopkins University
School of Medicine, 301 Mason F. Lord Drive, Suite 2500, Baltimore, MD
21224, USA
2Welch Center for Prevention Epidemiology and Clinical Research, Johns
Hopkins Medical Institutions, Baltimore, MD, USA
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Crews et al. BMC Nephrology  (2017) 18:7 
DOI 10.1186/s12882-016-0424-2
(population approximately 45,000) have somewhat
greater access to goods and services than those on
Nevis (population approximately 12,000), although
they share similar sociodemographic compositions.
The Caribbean Health and Education Foundation
(CHEF) proposed and conducted a screening program
for CKD, diabetes, and hypertension to ascertain the
prevalence of CKD and major CKD risk factors in St. Kitts
and Nevis. The major objective of CHEF’s Caribbean
Kidney Screening and Education Program (CKSEP) was to
provide rapid CKD screening among adults who are at
risk of developing CKD due to personal and/or family
history of diabetes, hypertension or CKD and inform these
individuals about CKD, enabling them to better manage
their risk. In this manuscript, we report estimates of
CKD and its risk factors (e.g. diabetes, hypertension




CHEF collaborated with the Nevis Renal Society, the
St. Kitts Diabetic Association and The Kidney Trust
Foundation to execute the CKSEP, utilizing The Kid-
ney Trust Foundation’s rapid CKD screening program
model to assist in identifying people with increased
risk of developing CKD and ESRD, and educate/em-
power them to better manage their illnesses. CKSEP
took place on the islands of Nevis and St. Kitts on
March 17–18 and March 20–21, 2014, respectively.
Three visiting nephrologists, in collaboration with
local primary care physicians and a local nephrologist,
provided on-site individual consultation to partici-
pants at the screenings in Nevis and St. Kitts. The
nephrologists and primary care providers were joined
by nurses, phlebotomists, medical students and lab
technician volunteers. Other volunteers were recruited
for registration of individuals, assistance with guiding
participants through the screening process, and crowd
management.
Participants
The CKSEP was advertised for several weeks on local
radio, television and at community-based clinics as an
opportunity for individuals with risk factors for CKD
(diabetes, hypertension and/or obesity) to be screened.
Adults ≥18 years of age were eligible. Otherwise, there
were no exclusions. All participants provided written
consent for screening.
Measurements
Participants were asked sociodemographic questions
(age, gender, race/ethnicity), and were asked about their
personal (self-report) and family history of diabetes,
hypertension and kidney disease, and the name of their
regular physician. During the screening, the CKSEP
team assessed participants’ height, weight [for body mass
index (BMI) (weight/height2) calculation], and seated
systolic and diastolic blood pressure (mmHg) using
automated cuffs. BMI 25 to 29.9 kg/m2 was considered
overweight, and ≥30 kg/m2 was considered obesity.
Systolic blood pressure ≥140 mmHg or diastolic blood
pressure ≥90 mmHg were considered diagnostic of
hypertension.
A venous blood sample for each participant was proc-
essed directly on site, using i-STAT Portable Clinical
Analyzer (Abbott Laboratories, Abbott Park, IL, USA),
which performs rapid blood analysis and displays quanti-
tative test results in approximately 3–5 min. Calibration
is automatically performed as part of the iSTAT System
test cycle. Quality assurance/performance of the iSTAT
System (as performed by The Kidney Trust staff ) was
verified using the internal or external electronic simula-
tor every 24 h of testing. Serum creatinine was assessed
using i-STAT. Estimated glomerular filtration rate
(eGFR) was calculated using the 4 variable Modification
of Diet in Renal Disease study equation [4] and used to
determine stage of CKD [5]. Estimated GFR <60 ml/
min/1.73 m2 was considered to define reduced eGFR.
Random serum glucose was assessed by fingerstick sam-
ples using commercially available glucometers (Contour
Next and Precision Xtra). Non-fasting fingerstick glu-
cose at or exceeding 200 mg/dL was considered diagnos-
tic of diabetes mellitus [6]. Urine dipsticks were used to
assess evidence of albuminuria (Siemens Multistix 10 SG
and Siemens CLINITEK Microalbumin 2). Urine albu-
min results were reported as 0-trace, 30–100 mg/dL,
100–300 mg/dL, and >300 mg/dL. Values 30 and above
were considered as evidence of albuminuria. Due to lim-
ited availability of urine dipsticks, only high risk partici-
pants in Nevis (i.e. those with known diabetes or
hypertension) underwent screening for albuminuria.
Data analysis
Screening data were initially recorded on paper forms
and later entered into an electronic database. Data were
analyzed individually and together for both St. Kitts and
Nevis. Comparisons were also made between islands.
Means and proportions for demographic and clinical
variables were obtained using t-tests and chi squared
tests where appropriate. Serum glucose and blood pres-
sure were described continuously, and as binary vari-
ables (yes/no for diabetes or hypertension). Overweight
and obesity were each described categorically. Estimated
GFR was described continuously and in categories and
stages of CKD. Albuminuria was described categorically.
Multivariable logistic regression was used to examine
the direction, magnitude and independence of the
Crews et al. BMC Nephrology  (2017) 18:7 Page 2 of 7
associations of demographic and clinical variables with
prevalent reduced eGFR (defined as <60 ml/min per
1.73 m2) or albuminuria. In the regression models, age
was modeled continuously, while all other covariates
were modeled as binary variables.
Results
A total of 1978 presented to the screening programs on
the islands of Nevis and St. Kitts and underwent screening.
In Nevis, 950 participants were screened at the Anglican
Church Hall in Charlestown. In St. Kitts, 1028 participants
were screened at two venues, which operated simul-
taneously - Newtown and McKnight Community Centers
in Basseterre.
Screening findings in Nevis
The participants screened in Nevis represented approxi-
mately 8% of the total population, which is approximately
12,000. The overwhelming majority of participants were
English-speaking. Those speaking Spanish or Saint Kitts
Creole were able to be accommodated by the language
skills of the screening team. The mean age was 49 years,
and the majority of participants were female (64%). The
overwhelming majority of participants were of black race
(Table 1). Many individuals screened had risk factors for
CKD, including 28% who self-reported a diagnosis of
hypertension and 16.8% who reported having diabetes.
Additionally, the average systolic blood pressure of the
screened population fell in the ‘stage 1 hypertension’ range
[7]. Notably, 8.2% of participants who underwent serum
glucose testing had a value exceeding 200 mg/dL, and 12
(17.1%) of these individuals were unaware of a diagnosis
of diabetes (based on their answers to our screening ques-
tionnaire). The majority of participants were found to be
either overweight (38%) or obese (38%). Overweight and
obesity were more prevalent among females, with females
comprising 62% of overweight and 75% of obese persons
screened.
Screening findings in St. Kitts
The 1028 persons screened in St. Kitts represented ap-
proximately 2% of the total population, which is esti-
mated to be 45,000. Similar to Nevis, participants were a
mean age of 49 years, the majority were female (66%),
and the overwhelming majority were of black race
(Table 1). A total of 36% self-reported a diagnosis of
hypertension and 23.6% reported having diabetes. Addi-
tionally, the average systolic blood pressure of the
screened population fell in the ‘pre-hypertension’ range.
Fully, 9.5% of participants who underwent serum glu-
cose testing had a value that exceeded 200 mg/dL, and
11 (17.5%) of these individuals were unaware of a diag-
nosis of diabetes. The majority of participants assessed
(n = 590) were found to be either overweight (32%) or
obese (44%). Overweight and obesity were more preva-
lent among females, with females comprising 56% of
overweight and 76% obese persons screened.
Kidney disease in Nevis and St. Kitts
Among the kidney disease measures administered, per-
sons were found to have a mean eGFR of 98 mL/min/
1.73 m2 (SD) and 4.7% had an eGFR <60 mL/min/
1.73 m2. Nevisians had a lower average eGFR than Kitti-
tians screened, but there were no differences in the preva-
lence of eGFR < 60 ml/min per 1.73 m2. The majority of
participants (88%) with an eGFR < 60 mL/min/1.73 m2
would be considered to have CKD stage 3 by National Kid-
ney Foundation guidelines if confirmed on repeat analyses
[5]. Eleven persons had more advanced CKD (eGFR <30/
CKD stages 4 and 5). A total of 929 Nevisians underwent
urine testing, and 126 individuals (13.5%) had a urine albu-
min level of at least 30 mg/dL, which is suggestive of kid-
ney damage. Five persons screened (0.5%) had significantly
elevated urine albumin (of at least 300 mg/dL) (Table 2).
Due to a limited supply of dipsticks, only 183 participants
underwent screening for urine albumin in St. Kitts. These
were primarily persons with risk factors for CKD (e.g. dia-
betes), and/or those identified to have reduced eGFR dur-
ing screening. Among them, 141 individuals had a urine
albumin of at least 30 mg/dL. Eleven persons screened in
St. Kitts had significantly elevated urine albumin (of at least
300 mg/dL).
Independent predictors of eGFR < 60 ml/min per
1.73 m2 in the overall population (both islands), included
age, self-reported and/or measured hypertension and
self-reported and/or lab-confirmed diabetes mellitus
(Table 3). Similar predictors were observed for both St.
Kitts and Nevis, however, hypertension was not a statis-
tically significant predictor of reduced eGFR in St. Kitts
following adjustment for obesity. Diabetes (self-reported
and/or lab-confirmed) was the only observed independent
predictor of albuminuria in Nevis.
Discussion
In the context of a screening program, we found that
CKD and its risk factors were prevalent among adults in
St. Kitts and Nevis, including 4.7% with reduced kidney
function and (in Nevis) 13.5% with albuminuria. Diabetes,
hypertension and obesity were highly prevalent in this
population, suggesting opportunities for CKD prevention
through early detection and evidence-based treatment of
these chronic conditions.
There is limited information available from the Caribbean
Renal Registry regarding CKD prevalence in the English-
speaking Caribbean. These data were not derived from
population-based screens, but rather were documented by
some participating providers of care delivered to their spe-
cific patients. For example, in Jamaica there are a reported
Crews et al. BMC Nephrology  (2017) 18:7 Page 3 of 7
968 patients (population 2.8 million) with CKD, which in-
cludes 576 patients on dialysis [8]. Trinidad and Tobago
(population 1.2 million) reported 564 patients on dialysis.
Diabetes and hypertension are the main causes of ESRD in
the English-speaking Caribbean as in the US. In Trinidad
and Tobago, Antigua and Barbuda and the British Virgin
Islands, diabetes is the primary cause of CKD (30.5, 44 and
56% respectively) with hypertension second (16.5, 23.3 and
28% respectively) [3]. In Jamaica and St. Lucia hypertension
is the most common etiology of CKD (35.2 and 53.3% re-
spectively) followed by diabetes (29.7 and 25.5% res-
pectively) [3]. The high prevalence of diabetes and
hypertension in St. Kitts/Nevis therefore increases the
risk of CKD in this population.
We detected a greater self-reported diabetes preva-
lence than previously documented by the Pan American
Table 1 Participant characteristics and diabetes, hypertension and obesity screening findings among adults in St. Kitts and Nevis,
overall and by island
Characteristic/finding All participants Results for all Number of Nevis
participants assessed
Nevis results Number of St. Kitts
participants assessed
St. Kitts results P*
Demographics
Age in years, mean (SD) 1978 49 (15) 950 49 (15) 1028 49 (15) 0.69
Age category, n (%) 1978 950 1028 0.06
< 40 years 541 (27) 252 (26.5) 289 (28.1)
40–49 years 401 (20) 217 (22.8) 184 (17.9)
50–59 years 528 (27) 248 (26.1) 280 (27.2)
≥ 60 years 508 (26) 233 (24.5) 275 (26.8)
Female gender, n (%) 1978 1285 (65) 950 609 (64) 1028 676 (66) 0.44
Race/ethnicity, n (%) 1978 950 1028 0.14
Black 1964 (99.3) 939 (98.8) 1025 (99.7)
White 5 (0.3) 4 (0.4) 1 (0.1)
Hispanic 9 (0.5) 7 (0.7) 2 (0.2)
Chronic Kidney Disease Risk Factors
Systolic blood pressure,
mean (SD)
1971 138 (66) 950 140 (63) 1021 136 (68) 0.13
Systolic blood pressure,
≥140 mmHg, n (%)
1971 761 (38.6) 950 412 (43.4) 1021 349 (34.2) <0.001
Diastolic blood pressure,
mean (SD)
1964 79 (15) 944 82 (13) 1020 76 (15) <0.001
Diastolic blood pressure,
≥90 mmHg, n (%)
1964 406 (20.7) 944 239 (25.3) 1020 167 (16.4) <0.001
Self-reported hypertension,
n (%)
1978 637 (32) 950 267 (28) 1028 370 (36) <0.001
Self-reported or measured
hypertension, n (%)
1978 1050 (53.1) 950 527 (56) 1028 523 (50.9) 0.04
Serum glucose in mg/dL,
mean (SD)
1518 127 (64) 857 128 (60) 661 125 (69) 0.44
Serum glucose ≥200 mg/dL,
n (%)
1518 133 (8.8) 857 70 (8.2) 661 63 (9.5) 0.35
Self-reported diabetes mellitus,
n (%)
1978 403 (20.4) 950 160 (16.8) 1028 243 (23.6) <0.001
Self-reported or lab-confirmed
diabetes mellitus, n (%)
1978 426 (21.5) 950 172 (18.1) 1028 254 (24.7) <0.001
Overweight
(BMI 25 to 29.9 kg/m2), n (%)
1494 529 (35.4) 904 340 (37.6) 590 189 (32.0) 0.03
Obesity (BMI ≥30 kg/m2), n (%) 1494 602 (40.3) 904 345 (38.2) 590 257 (43.6) 0.04
Abbreviations: SD standard deviation, n number of individual participants, BMI body mass index
*P values indicate whether findings on Nevis versus St. Kitts were statistically significantly different
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Health Organization for St. Kitts/Nevis (8%) [2]. The
World Health Organization (WHO) also reported a
greater than average regional diabetes prevalence among
women in St. Kitts/Nevis [3]. The mean prevalence of
diabetes in the WHO Americas region is 11.5% for men
and 9.9% for women [3]. According to the WHO, 14.6%
of men and 13.6% of women in St. Kitts/Nevis have dia-
betes [3]. It should be noted that the WHO estimates
prevalence based on an elevated fasting glucose or use
of medication for diabetes. The high self-reported preva-
lence in our sample should therefore be interpreted with
caution, particularly since one screening site in St. Kitts
was in close proximity to a diabetes care center. The
self-reported prevalence of diabetes in St. Kitts was
23.6%. Still, the Nevis screening center was not close to
such a facility and the self-reported diabetes prevalence
was still elevated at 16.8%. Our ability to diagnose dia-
betes was limited since we were not able to measure
fasting glucose or hemoglobin A1C. However, the high
proportion (8.7%) found to have a random serum glu-
cose ≥ 200 mg/dl, may provide an estimate of the level of
blood glucose control in the population.
The 2008 WHO data for St. Kitts/Nevis reported
40.7% for obesity and 37.4% for hypertension [9]. These
values were consistent with our screening findings. It
should be noted that proportion measured to be obese
in our screening program as well as the WHO data re-
flect a significantly greater mean than the regional
Americas average (23.5% for males and 29.7% for females)
[10]. The proportion with hypertension we detected is
consistent with regional estimates that reflect a signifi-
cantly higher disease burden in individuals of African
descent. In the US, the age-adjusted prevalence of
hypertension overall is 29.1%, while for black adults it
is 42% [11].
There were limitations of our screening program that
deserve consideration. First, we included adults who pre-
sented for screening and targeted the advertisements
about our program to high-risk individuals. Further, we
did not conduct population-based sampling of partici-
pants, or have an available reference point (i.e. known
age/gender distribution of CKD) to which to compare
our participants. Thus, we may have detected a higher
proportion of individuals with CKD and its risk factors
than would be obtained in a population-based sample.
Second, we did not standardize the measurement of blood
pressure, and therefore, measurement error was possible.
Third, we were limited in our ability to administer urine
albumin tests to all participants, and therefore preferen-
tially did so among higher risk participants, which make
Table 2 Kidney disease screening findings among adults in St. Kitts and Nevis, overall and by island
Characteristic/Finding All participants
N
Results for all Number of Nevis
participants assessed






Serum creatinine in mg/dL,
mean (SD)
1978 0.9 (0.3) 950 0.9 (0.3) 1028 0.9 (0.4) 0.04
Estimated GFR (mL/min/1.73 m2)
mean (SD)
1978 98 (30) 950 95 (30) 1028 100 (29) <0.001
Estimated GFR <60 mL/min/1.73 m2,
n (%)
1978 93 (4.7) 950 44 (4.6) 1028 49 (4.8) 0.89
Estimated GFR <45 mL/min/1.73 m2,
n (%)
1978 32 (1.6) 950 18 (1.9) 1028 14 (1.4) 0.35
CKD stage, n (%) [among persons
with estimated GFR < 60]
93 – – – – – 0.87
-Stage 3 (estimated GFR 30 to 59) 82 (88.2) – 38 (86.4) – 44 (90)
-Stage 4 (estimated GFR 15–29) 9 (9.7) – 5 (11.4) – 4 (8)
-Stage 5 (estimated GFR <15) 2 (2.2) – 1 (2.3) – 1 (2)
Urine protein, n (%) – – 929
0 to trace mg/dL – 803 (86.4)
≥ 30 to <100 mg/dL – 103 (11.1)
≥ 100 to <300 mg/dL – 18 (1.9)
≥ 300 mg/dL – 5 (0.5)
Urine protein ≥30 mg/dL, n (%) – – 929 126 (13.5)
Abbreviations: SD standard deviation, n number of individual participants, GFR glomerular filtration rate, BMI body mass index
*P values indicate whether findings on Nevis versus St. Kitts were statistically significantly different
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our albuminuria findings only generalizable to individuals
with CKD risk factors.
Conclusions
To our knowledge this is the first report of a screening ac-
tivity of this magnitude for CKD in the Caribbean. This
first effort lays the ground work for developing health
strategies for prevention and treatment of CKD and ESRD
and their risk factors in St. Kitts and Nevis, diseases of
which are associated with high cost, morbidity and mor-
tality. Development of public health strategies to improve
access to primary care, treatment of conditions such as
diabetes and hypertension, increasing public health
awareness of obesity and increasing awareness of the
benefits of lifestyle changes, as well as education of pri-
mary care providers as to how to assess, treat, and
intervene on their patients for these most prevalent
causes of CKD/ESRD, are specific recommendations
that may help to eventually decrease the incidence of
CKD and ESRD in St. Kitts and Nevis.
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